Paper21990299
Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.
Yang D and 6 others. JAMA, 2011. Cited by 476 papers, by iCite.
Cite this record
ConductScience Library. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. Papers, record 21990299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21990299
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genes, BRCA1 | Major topic |
| Genes, BRCA2 | Major topic |
| Mutation | Major topic |
| Ovarian Neoplasms | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Antineoplastic Agents | |
| DNA Methylation | |
| Databases, Factual | |
| Disease Progression | |
| Drug Resistance, Neoplasm | |
| Female | |
| Genomic Instability | |
| Humans | |
| Middle Aged | |
| Phenotype | |
| Prognosis | |
| Promoter Regions, Genetic | |
| Survival Analysis | |
| Treatment Outcome |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed and NIH | NIH RePORTER |
| P50 CA083639 | NCI NIH HHS | United States | P50CA083639 | PubMed and NIH | NIH RePORTER |
| U24 CA143835 | NCI NIH HHS | United States | U24CA143835 | PubMed and NIH | NIH RePORTER |
| U24CA143835 | NCI NIH HHS | United States | U24CA143835 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03976999 | Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers | Results |
Source ClinicalTrials.gov
Comments and corrections5
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 21990304 | Defining variations in survival of BRCA1 and BRCA2 mutation carriers. | https://conductscience.org/library/papers/21990304 | PubMed |
| Comment in | 22024946 | Genetics: BRCA2 mutation offers response and survival advantages. | https://conductscience.org/library/papers/22024946 | PubMed |
| Comment in | 22089419 | Genetics. BRCA inequality. | https://conductscience.org/library/papers/22089419 | PubMed |
| Comment in | 22274678 | BRCA1 and BRCA2 mutations in ovarian cancer. | https://conductscience.org/library/papers/22274678 | PubMed |
| Comment in | 22274679 | BRCA1 and BRCA2 mutations in ovarian cancer. | https://conductscience.org/library/papers/22274679 | PubMed |
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11836499 | BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. | Nat Genet | 2002 | https://conductscience.org/library/papers/11836499 | PubMed |
| 2 | 11786575 | Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. | J Clin Oncol | 2002 | https://conductscience.org/library/papers/11786575 | PubMed |
| 3 | 8705994 | Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. | Cancer Res | 1996 | https://conductscience.org/library/papers/8705994 | PubMed |
| 4 | 16047333 | Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma. | Cancer | 2005 | https://conductscience.org/library/papers/16047333 | PubMed |
| 5 | 18087219 | BRCA1 regulates gamma-tubulin binding to centrosomes. | Cancer Biol Ther | 2007 | https://conductscience.org/library/papers/18087219 | PubMed |
| 6 | 15965487 | BRCA1 participates in DNA decatenation. | Nat Struct Mol Biol | 2005 | https://conductscience.org/library/papers/15965487 | PubMed |
| 7 | 8875917 | Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8875917 | PubMed |
| 8 | 12237281 | Cancer Incidence in BRCA1 mutation carriers. | J Natl Cancer Inst | 2002 | https://conductscience.org/library/papers/12237281 | PubMed |
| 9 | 18955455 | "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18955455 | PubMed |
| 10 | 11239456 | Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. | Mol Cell | 2001 | https://conductscience.org/library/papers/11239456 | PubMed |
| 11 | 16714056 | What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? | Gynecol Oncol | 2006 | https://conductscience.org/library/papers/16714056 | PubMed |
| 12 | 17081976 | The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly. | Cell | 2006 | https://conductscience.org/library/papers/17081976 | PubMed |
| 13 | 17525340 | Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. | Science | 2007 | https://conductscience.org/library/papers/17525340 | PubMed |
| 14 | 12470990 | The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. | Trends Mol Med | 2002 | https://conductscience.org/library/papers/12470990 | PubMed |
| 15 | 21720365 | Integrated genomic analyses of ovarian carcinoma. | Nature | 2011 | https://conductscience.org/library/papers/21720365 | PubMed |
| 16 | 11832208 | Cancer susceptibility and the functions of BRCA1 and BRCA2. | Cell | 2002 | https://conductscience.org/library/papers/11832208 | PubMed |
| 17 | 11239455 | BRCA2 is required for homology-directed repair of chromosomal breaks. | Mol Cell | 2001 | https://conductscience.org/library/papers/11239455 | PubMed |
| 18 | 12712470 | Improved survival in women with BRCA-associated ovarian carcinoma. | Cancer | 2003 | https://conductscience.org/library/papers/12712470 | PubMed |
| 19 | 17643121 | CCDC98 targets BRCA1 to DNA damage sites. | Nat Struct Mol Biol | 2007 | https://conductscience.org/library/papers/17643121 | PubMed |
| 20 | 17643122 | CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response. | Nat Struct Mol Biol | 2007 | https://conductscience.org/library/papers/17643122 | PubMed |
Cited by311
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 476 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42940036 | Alternative Splicing of Homologous Recombination Genes Is Associated with Homologous Recombination Deficiency and Immunoregulatory Phenotypes in Breast Cancer. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940036 | PubMed |
| 42820288 | Expanding the therapeutic scope of PARP inhibitors in breast cancer: current indications and future directions. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42820288 | PubMed |
| 42778549 | Heterogeneity in cancer: molecular mechanisms and therapeutic strategies. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42778549 | PubMed |
| 42394702 | Homologous recombination pathway alterations in basal-like breast cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42394702 | PubMed |
| 42348196 | Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors. | JAMA Oncol | 2026 | https://conductscience.org/library/papers/42348196 | PubMed |
| 42296035 | SF3A3 in Liver Hepatocellular Carcinoma: Oncogenic Role and Prognostic Significance. | Oncology | 2026 | https://conductscience.org/library/papers/42296035 | PubMed |
| 42121636 | Association of BRCA Mutation Status with Clinical Outcomes in High-Grade Serous Ovarian Cancer. | Healthcare (Basel) | 2026 | https://conductscience.org/library/papers/42121636 | PubMed |
| 41724111 | Quantifying rate-limiting genetic variation in breast and ovarian tumourigenesis. | EBioMedicine | 2026 | https://conductscience.org/library/papers/41724111 | PubMed |
| 41711981 | Evaluating tumor chemosensitivity: a head-to-head comparison of the prognostic value of KELIM (modeled CA125 elimination rate constant K) and RECIST 1.1 (radiological response valuation criteria in solid tumors) in ovarian cancer. | Arch Gynecol Obstet | 2026 | https://conductscience.org/library/papers/41711981 | PubMed |
| 41646477 | A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer. | ESMO Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/41646477 | PubMed |
| 41567614 | Impact of carboplatin desensitization therapy on progression-free survival in gynecologic cancers. | Gynecol Oncol Rep | 2026 | https://conductscience.org/library/papers/41567614 | PubMed |
| 41354605 | Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations. | Eur Urol Focus | 2026 | https://conductscience.org/library/papers/41354605 | PubMed |
| 41299328 | CLIC3 emerges as a novel prognostic biomarker and therapeutic target in triple-negative breast cancer through integrated multi-omics analysis. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41299328 | PubMed |
| 41264162 | Clinical and molecular determinants of response to maintenance olaparib for primary and recurrent epithelial ovarian carcinoma. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/41264162 | PubMed |
| 41256539 | An Interpretable Deep Learning Framework for Biomarker Discovery in Complex Disease Survival Outcomes. | bioRxiv | 2025 | https://conductscience.org/library/papers/41256539 | PubMed |
| 41093344 | Prognostic significance of tumour-infiltrating T lymphocytes in ovarian cancer: a protocol for systematic review and meta-analysis. | BMJ Open | 2025 | https://conductscience.org/library/papers/41093344 | PubMed |
| 41068641 | Germline and somatic mutational variants of Tunisian high grade serous ovarian cancer identified by next-generation sequencing. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41068641 | PubMed |
| 40979227 | Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship. | Ther Adv Med Oncol | 2025 | https://conductscience.org/library/papers/40979227 | PubMed |
| 40948768 | Panoramic view of MDH1: driving cancer progression and shaping the tumor immune microenvironment. | Front Immunol | 2025 | https://conductscience.org/library/papers/40948768 | PubMed |
| 40923759 | Moss BRCA2 lacking the canonical DNA-binding domain promotes homologous recombination and binds to DNA. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/40923759 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL3 | 602 | PubTator's text mining | https://conductscience.org/library/genes/602 | NCBI Gene |
| BLM | 641 | PubTator's text mining | https://conductscience.org/library/genes/641 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| RAD51 | 5888 | PubTator's text mining | https://conductscience.org/library/genes/5888 | NCBI Gene |
| TP63 | 8626 | PubTator's text mining | https://conductscience.org/library/genes/8626 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21990299
GET https://conductscience.org/api/papers/v1/21990299/references?page=2